Samara Capital in fray to invest in PE-backed contract drugmaker

Homegrown private equity firm Samara Capital has emerged as one of the frontrunners to invest in a Mumbai-based pharmaceutical development and manufacturing company, two people aware of the development told VCCircle. Samara Capital, which sold its Oaknet Healthcare platform to Eris Lifesciences in 2022, is in advanced stages of talks to ......